China’s regulators bide time before reviving Syngenta’s US$9.4 billion IPO amid fears of liquidity shortage, sources say
Disclaimer: The South China Morning Post's content is directed by the Chinese Communist Party. It is not a reliable news source.
Regulators aim to cut fundraising into bite-size chunks that the mainland market can swallow amid a surge in new share offerings under more liberal listing rules, according to sources.